<乌鸦传媒>Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status Oct 17, 2020
<乌鸦传媒>Positive Anti-PD-1 Data in Gastric, Esophageal Cancer Better OS, PFS with nivolumab, pembrolizumab in advanced/metastatic disease Sep 23, 2020
<乌鸦传媒>Immunotherapy Falls Short Again in Ovarian Cancer No PFS benefit in advanced disease with addition of atezolizumab to chemo, bevacizumab Sep 23, 2020
<乌鸦传媒>No Luck for Chemo-Free Tx in First-Line Bladder Cancer Durvalumab alone or with tremelimumab no better than chemotherapy Sep 22, 2020
<乌鸦传媒>No Benefit With Anti-PD-L1 Drug in Metastatic TNBC Lack of progression-free, overall survival boost with atezolizumab contrast with prior trial Sep 22, 2020
<乌鸦传媒>Skip Chemo for Older Patients With HER2+ Breast Cancer? Less than one-month survival loss at 3 years with trastuzumab monotherapy Sep 18, 2020
<乌鸦传媒>Raising the Bar for Myelofibrosis Therapy Development Rational combinations, new targets, and a first-ever phase III trial with a survival endpoint Sep 14, 2020
<乌鸦传媒>New Insights Into Radiation-Induced Hair Loss Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
<乌鸦传媒>Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<乌鸦传媒>Alex Trebek, Harry Reid and Their Pancreatic Cancer Treatment Exploring a 'triangle offense' against the disease Jul 28, 2020
<乌鸦传媒>Survival Effect of pCR Elusive in Breast Cancer 80% lower risk of recurrence with surrogate endpoint, but link to survival unproven Jul 23, 2020
<乌鸦传媒>Older Age Should Not Rule Out Chemo in Breast Cancer Patients Providers should consider patient priorities when discussing treatment Jul 17, 2020
<乌鸦传媒>Brief Quasi-Fasting Diet Boosts Breast Cancer Chemo Response Randomized trial in neoadjuvant setting Jun 28, 2020
<乌鸦传媒>New Standard for Relapsed/Refractory Multiple Myeloma? Triplet regimen significantly extended median PFS versus doublet in IKEMA study Jun 15, 2020
<乌鸦传媒>Second Surgery Gets OS Win in Recurrent Ovarian Cancer Survival improved by nearly 8 months with cytoreductive surgery at first relapse Jun 02, 2020
<乌鸦传媒>Early Palliation: Boon for AML Patients on Intensive Chemo Intervention led to marked improvements in QoL, mental distress, end-of-life care Jun 02, 2020
<乌鸦传媒>New First-Line Standard in Metastatic Bladder Cancer "High bar to beat" as avelumab maintenance improves median survival by over 7 months May 28, 2020
<乌鸦传媒>Avelumab Flops Again in Ovarian Cancer Another negative phase III trial, now in the first-line setting May 19, 2020
<乌鸦传媒>Five Days of G-CSF Adequate for Breast Cancer Chemo Rate of chemotherapy-induced febrile neutropenia similar to 7- to 10-day regimen May 08, 2020
<乌鸦传媒>Honing Chemo Use in Small Breast Tumors Clearest survival benefit for 8-10 mm tumors in HR/HER2-positive disease May 03, 2020
<乌鸦传媒>Add-On Metformin No Help in Advanced Endometrial Cancer Trial highlights deep racial disparities in treatment response, survival outcomes Apr 27, 2020
<乌鸦传媒>Herceptin Boosts OS in HER2-Positive Uterine Cancer New data bolster targeted approach for aggressive tumor type Apr 24, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>CRC: Upfront, Re-Introduction of FOLFOXIRI Most Effective, but at What Cost? Modest survival improvement comes with side effects, toxicity even in healthiest patients Mar 13, 2020
<乌鸦传媒>Bringing Transplant to More Patients With AML Conditioning with radiolabeled antibody leads to successful transplantation in 84% of older patients Feb 25, 2020
<乌鸦传媒>Myeloablative Therapy Prevails in AML Transplant Study Better survival, fewer relapses compared with reduced-intensity conditioning Feb 21, 2020
<乌鸦传媒>Shannen Doherty's Stage IV Breast Cancer "Beverly Hills, 90210" star says she's "petrified" Feb 20, 2020
<乌鸦传媒>Bell Ringing Not So Joyous for Cancer Patients? Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
<乌鸦传媒>Bad News on Anti-HER2 Heart Effects Exercise, however, may help improve cardio fitness in breast cancer survivors Jan 15, 2020
<乌鸦传媒>Chinese Herbal May Be Chemoprotective Against Colorectal Cancer Polypectomy patients given the supplement developed fewer colorectal adenomas Jan 13, 2020
<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 31, 2019
<乌鸦传媒>PD-1 vs PD-L1 Inhibitors: Do Outcomes Differ? Meta-analysis suggests they aren't equivalent Dec 27, 2019
<乌鸦传媒>Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBC Similar PFS with chemo, palbociclib plus exemestane or fulvestrant after progression on aromatase inhibitor Dec 13, 2019
<乌鸦传媒>Checkpoints Show Different Outcomes in Breast Cancer Atezolizumab misses complete response benefit in triple negative patients Dec 13, 2019
<乌鸦传媒>T-DM1 Falls Short as Less-Toxic Option for Early Breast Cancer Promising efficacy but higher discontinuation rates and cost likely a deterrent Dec 13, 2019
<乌鸦传媒>Edging Closer to OS Benefit With Novel Anti-HER2 Drug Larger benefit with margetuximab in most common HER2 breast cancer phenotype Dec 12, 2019
<乌鸦传媒>New Standard for Metastatic HER2 Breast Cancer Consistent PFS, OS benefit with combination including oral HER2 inhibitor tucatinib Dec 11, 2019
<乌鸦传媒>Survival Bump With Oral AML Maintenance Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients Dec 10, 2019
<乌鸦传媒>Docetaxel First May Boost Survival in mCRPC Superior outcomes observed versus approach where chemo follows newer agents Dec 05, 2019
<乌鸦传媒>IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR Prognostic tool may predict who is likely to achieve a relatively long remission Oct 15, 2019
